{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-25-001602","form_type":"8-K","ticker":"LIPO","cik":"0001347242","company_name":"LIPELLA PHARMACEUTICALS INC.","filed_at":"2025-10-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.207739+00:00","generated_at":"2026-05-17T04:09:56.482755+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"confidence":"high","headline":"Lipella Pharmaceuticals CMO and Board Member Michael Chancellor to retire effective Dec 4, 2025","bullets":["Dr. Michael Chancellor notified intention to retire as Chief Medical Officer and Board member.","Retirement effective December 4, 2025; no disagreement with company cited.","Dr. Chancellor's departure planned and not due to policy or operational disputes."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-25-001602","json":"https://secwatch.observer/filing/0001753926-25-001602.json","markdown":"https://secwatch.observer/filing/0001753926-25-001602.md","text":"https://secwatch.observer/filing/0001753926-25-001602.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347242/000175392625001602/0001753926-25-001602-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347242/000175392625001602/g084974_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:09:56.482755+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}